AT
MRK icon

Avalon Trust’s Merck MRK Stock Holding History

Avalon Trust’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.7M Sell
13,249
-10
-0.1% -$1.17K 0.1% 62
2026
Q1 		$1.59M Buy
13,259
+709
+6% +$81.9K 0.11% 59
2025
Q4 		$1.32M Sell
12,550
-5,750
-31% -$540K 0.09% 64
2025
Q3 		$1.54M Sell
18,300
-501
-3% -$41.3K 0.1% 59
2025
Q2 		$1.49M Sell
18,801
-16,491
-47% -$1.31M 0.11% 63
2025
Q1 		$3.17M Sell
35,292
-155,796
-82% -$14.5M 0.25% 49
2024
Q4 		$19M Sell
191,088
-1,063
-0.6% -$110K 1.35% 23
2024
Q3 		$21.8M Buy
192,151
+2,195
+1% +$261K 1.61% 21
2024
Q2 		$23.5M Sell
189,956
-385
-0.2% -$49.6K 1.86% 17
2024
Q1 		$25.1M Buy
190,341
+467
+0.2% +$57.6K 2.06% 13
2023
Q4 		$20.7M Buy
189,874
+944
+0.5% +$98K 1.89% 16
2023
Q3 		$19.5M Buy
188,930
+1,000
+0.5% +$108K 1.93% 18
2023
Q2 		$21.7M Sell
187,930
-75
-0% -$8.52K 1.96% 18
2023
Q1 		$20M Buy
+188,005
New +$20.3M 1.98% 20

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Avalon Trust's MRK Position: Q2 2026 in Review

Avalon Trust reduced its Merck (MRK) stake by 0.08% in Q2 2026, selling an estimated $1.17K and leaving 13,249 shares worth $1.7M. The position accounts for 0.1% of the portfolio, ranked #62.

Avalon Trust first reported a position in MRK in Q1 2023 and has held it in 14 quarters since. The position peaked at $25.1M in Q1 2024. 3,834 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Avalon Trust held 13,249 shares of Merck worth $1.7M as of Q2 2026.
  • Avalon Trust sold 10 Merck shares in Q2 2026, an estimated $1.17K.
  • Merck made up 0.1% of Avalon Trust's portfolio in Q2 2026, its #62 holding.
  • Avalon Trust first reported a position in Merck in Q1 2023 and has held it in 14 quarters since.
  • Avalon Trust's Merck position peaked at $25.1M in Q1 2024.
  • 3,834 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Avalon Trust's 13F filing for Q2 2026, filed 6 Aug 2026.